Sartorius Strengthens its Expertise and Technologies to Support the Growing Cell and Gene Therapy Industry
Cell and gene based therapies present a new treatment paradigm that have the potential to address clinical needs that are unmet by current small molecule and biotherapeutic approaches.
Developers and manufacturers of these new therapies are looking for technology and service solutions that provide process integrity, robust supply chain support, standardization and automation.
Sartorius is a well respected global solution provider within the biologics industry, especially for antibody and vaccine production. Our proven products and services are being diversified for upstream and downstream processing of cells and viruses for allogeneic and autologous advanced therapies. Therapy development can benefit from our single use systems, intelligent equipment and analytics. Combined, these help speed up your process development and support your manufacturing goals.
Please ask our specialists for more information about our portfolio for any stage of your individual process.
- Cellular Immunotherapy
- Gene Therapy and Viral Vectors
- Cell Therapy